BioCentury
ARTICLE | Clinical News

Avectin gene transfer technology: Trial to begin after FDA filing

September 19, 1994 7:00 AM UTC

Applied Immune Sciences Inc. (AISX), Santa Clara, Calif. Product: Avectin gene transfer technology, which uses viral elements and liposomes, to transfer the gene for interleukin-2 into tumor cells Ind...